跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TOLVAPTAN LUPIN tolvaptan 15 mg + 45 mg tablet blister composite pack - TGA Drug Approval Details
Approvals
/
TGA
/
TOLVAPTAN LUPIN tolvaptan 15 mg + 45 mg tablet blister composite pack
Approved
STANDARD
TOLVAPTAN LUPIN tolvaptan 15 mg + 45 mg tablet blister composite pack
Lupin Australia Pty Limited
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
459e21df2e45f2b0
Company
Lupin Australia Pty Limited
Type
Standard
Approval Details
Approval Id
459e21df2e45f2b0
Product Name
TOLVAPTAN LUPIN tolvaptan 15 mg + 45 mg tablet blister composite pack
Artg Id
417526
Artg Name
TOLVAPTAN LUPIN tolvaptan 15 mg + 45 mg tablet blister composite pack
Sponsor
Lupin Australia Pty Limited
Company Detail Path
/organization/lupin-australia-pty-limited
Artg Date
2024-10-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/6f03979d3dd211c785f9a7e7e5c6907d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1a1de51cf7563e8c7d2a47939abef94e.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
459e21df2e45f2b0
Type
Standard
Back to TGA Approvals